Valneva Reports Positive Phase 1 Results for Secon...
Category : Clinical Trial Update 6 November 2025October 2025 – Saint-Herblain, France: Valneva SE, a specialty vaccine company, has reported p...
Clinical Trial Update
Ascletis Showcases Promising Data from Obesity Dru...
Category : Clinical Trial Update 5 November 2025ASC30 oral tablet achieves up to 6.5% placebo-adjusted weight reduction; injectable formulation demo...
MetaVia Presents Positive Phase 1 and Preclinical...
Category : Clinical Trial Update 5 November 2025DA-1726 demonstrates favorable safety, dose-proportional pharmacokinetics, and meaningful weight los...
Spinogenix Reports Positive Phase 2a Results for A...
Category : Clinical Trial Update 5 November 2025SPG302 shows potential to slow disease progression and improve neuronal function in ALS patients...
Amgen to Present New Data on Repatha and Cardiovas...
Category : Clinical Trial Update 4 November 2025Amgen announced that new data from its cardiovascular portfolio, including late-breaking results fro...
Latest Newsletter Post
-
FDA Grants Orphan Drug Designation..
6 November 2025
-
Cipla to Acquire 100% Stake in Inzp..
6 November 2025
-
Valneva Reports Positive Phase 1 Re..
6 November 2025
-
Spinogenix Reports Positive Phase 2..
5 November 2025
-
MetaVia Presents Positive Phase 1 a..
5 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com